Literature DB >> 35718122

miR-150-5p inhibits nasopharyngeal cancer genesis by suppressing PYCR1.

Zhiqun Li1, Xiaoliu Zhou1, Jiajun Huang1, Zhencai Xu1, Chengliang Xing1, Junwei Yang1, Xuejun Zhou2.   

Abstract

BACKGROUND: Nasopharyngeal cancer (NPC) is a rare cancer type with a low five-year survival rate. Dysregulation of PYCR1 and miR-150-5p has been involved in the development of various cancers. However, the molecular mechanism of the miR-150-5p-PYCR1 axis in NPC remains unclear.
METHODS: The expressions of miR-150-5p and PYCR1 in NPC tissues and cells were measured by RT-qPCR. The luciferase assay and RNA pull-down assay were used to confirm the interaction between miR-150-5p and PYCR1. The function of overexpression of miR-150-5p and PYCR1 were detected by cell viability, proliferation, migration and invasion in NPC C666-1 and SUNE-1 cells.
RESULTS: The miR-150-5p expression was reduced in NPC tissues and cells and negatively correlated with PYCR1 level. Upregulation of miR-150-5p conspicuously repressed cell growth. However, upregulation of PYCR1 significantly facilitated the development of NPC, which further suppressed NPC tumorigenesis by abolishing the effect of miR-150-5p.
CONCLUSIONS: We clarified that miR-150-5p attenuated NPC tumorigenesis through reducing PYCR1 expression. This provides a new perspective of NPC involving both miR-150-5p and PYCR1 for the treatment of NPC.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  PYCR1; miR-150-5p; nasopharyngeal cancer

Year:  2022        PMID: 35718122     DOI: 10.1016/j.amjms.2022.06.004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  1 in total

1.  Selective Loading and Variations in the miRNA Profile of Extracellular Vesicles from Endothelial-like Cells Cultivated under Normoxia and Hypoxia.

Authors:  Anny Waloski Robert; Bruna Hilzendeger Marcon; Addeli Bez Batti Angulski; Sharon de Toledo Martins; Amanda Leitolis; Marco Augusto Stimamiglio; Alexandra Cristina Senegaglia; Alejandro Correa; Lysangela Ronalte Alves
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.